Nalaganje...
How I treat refractory chronic graft-versus-host disease
Approximately 35% to 50% of patients otherwise cured of hematologic malignancies after allogeneic hematopoietic stem cell transplantation will develop the pleomorphic autoimmune-like syndrome known as chronic graft-versus-host disease (cGVHD). Since in 2005, National Institutes of Health (NIH) conse...
Shranjeno v:
| izdano v: | Blood |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6418480/ https://ncbi.nlm.nih.gov/pubmed/30674472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-04-785899 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|